ANTIVIRAL THERAPY, cilt.23, sa.8, ss.647-653, 2018 (SCI-Expanded)
Background: Haemorrhagic cystitis (HC) is usually a serious complication in allogeneic haematopoietic stem cell transplantation (allo-HSCT) recipients. In this study, our aim was to define risk factors and outcomes for patients with HC in an allo-HSCT setting.